Global vaccination strategy to eradicate COVID-19: Beyond science

Simple item page
dc.contributor.authorSayegh, Mohamed H.
dc.contributor.authorMerhi, Alaa
dc.contributor.authorNaal, Hady
dc.contributor.authorSaleh, Shadi S.
dc.contributor.departmentGlobal Health Institute
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.facultyGlobal Health Institute
dc.contributor.facultyFaculty of Health Sciences (FHS)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T12:19:20Z
dc.date.available2025-01-24T12:19:20Z
dc.date.issued2021
dc.description.abstractCoronavirus disease-19 (COVID-19) was declared a pandemic on March 11th, 2020 by the World Health Organization (WHO). To control the pandemic, global efforts have produced promising vaccines, currently at different stages of clinical development, with 5 approved by the WHO and 14 approved by at least one country (Table 1). Despite continuous vaccine administration, several challenges to implementing a global vaccination strategy emerged, including limited vaccine production capacity, regulatory delays, politicization of public health interventions, resource constraints, and cultural issues. These challenges have generated increasing concerns as new strains of SARS-COV-2, the coronavirus that causes COVID-19, have emerged © 2021 The Author(S)
dc.identifier.doihttps://doi.org/10.7189/JOGH.11.03113
dc.identifier.eid2-s2.0-85122040020
dc.identifier.pmid34858592
dc.identifier.urihttp://hdl.handle.net/10938/34134
dc.language.isoen
dc.publisherUniversity of Edinburgh
dc.relation.ispartofJournal of Global Health
dc.sourceScopus
dc.subjectCovid-19
dc.subjectHumans
dc.subjectSars-cov-2
dc.subjectVaccination
dc.subjectHuman
dc.titleGlobal vaccination strategy to eradicate COVID-19: Beyond science
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2021-2736.pdf
Size:
567.4 KB
Format:
Adobe Portable Document Format
Download

Collections

Global Health Institute